US Pharma Eli Lilly to invest $1 Billion for global medicine supply capacity in Hyderabad

Dusmanta Behera
Dusmanta Behera - Editor-in-Chief
1 Min Read

NewzVille Desk

Telangana has secured an investment of one billion US dollars from US pharma major Eli Lilly to expand its manufacturing and global medicine supply capacity in Hyderabad. The announcement has been made after a delegation from the company met Telangana Chief Minister A Revanth Reddy and State Industries Minister D Sridhar Babu in Hyderabad yesterday.

The company inaugurated its Global Capability Centre (GCC) in Hyderabad in August this year. An official release stated that despite strong interest from several other states, Eli Lilly chose Telangana owing to the favourable ecosystem, availability of skilled manpower, infrastructure, and proactive government support.

It further said that with the new facilities, Eli Lilly is set to manufacture in Telangana and supply globally. The One-billion-dollar investment by Eli Lilly reflects the company’s interest in Telangana beyond its GCC operations and focuses on developing new medicines to treat diabetes and obesity, Alzheimer’s disease, cancer and autoimmune conditions

Share This Article
Dusmanta Behera
By Dusmanta Behera Editor-in-Chief
Follow:
Founded in 2024, NewzVille has got some name and fame. With more than 28 years of long journalistic career, the Editor-in-Chief had remained in various key positions at News Today Pvt Ltd, ETV Networks, Lok Sabha TV, Rajya Sabha TV, and Sansad TV. As an accredited Video Journalist for more than 17 years under Ministry of Information &Broadasting, Government of India covered State Visits of Prime Minister and Vice President. With coverage spanning 2 General Elections and more than 18 Assembly Elections, notable work includes national security series, live chamber telecasts, and audience-favorite documentaries. Key interests remain in Documentaries on Armed Forces and Travelogues.
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *